Impact of H-Type Hypertension on Pericarotid Adipose Tissue and Plaque Characteristics Based on Computed Tomography

Ying Liu1, Lun Xu2, Yan Gu1

  • 1Department of Radiology, The Affiliated Lianyungang Hospital of Xuzhou Medical University, Lianyungang, Jiangsu, China (mainland).

Insights

H-type hypertension is linked to inflammatory changes in pericarotid adipose tissue (PCAT), detectable by CT angiography. PCAT net enhancement values can predict carotid plaque vulnerability.

Area of Science:

  • Cardiovascular Imaging
  • Vascular Biology
  • Radiology

Background:

  • Inflammatory changes in pericarotid adipose tissue (PCAT) are associated with carotid atherosclerosis.
  • H-type hypertension is a risk factor for cardiovascular diseases.
  • CT angiography (CTA) can visualize PCAT and carotid plaques.

Purpose of the Study:

  • To analyze the correlation between PCAT inflammatory changes, carotid plaque characteristics, and H-type hypertension using CTA.
  • To explore the utility of CTA in preventing and treating carotid atherosclerosis.

Main Methods:

  • Retrospective analysis of 135 patients undergoing head and neck CTA.
  • Measurement of PCAT attenuation and net enhancement values, plaque burden, and remodeling index.
  • Logistic regression and correlation analyses to assess relationships between hypertension, PCAT, and plaque characteristics.

Main Results:

  • PCAT attenuation and net enhancement values increased with the severity of hypertension and were more pronounced in patients with high homocysteine (Hcy) levels.
  • Hcy, PCAT attenuation values, and PCAT net enhancement values were identified as independent risk factors for carotid atherosclerotic plaque vulnerability.
  • PCAT net enhancement values showed a significant correlation with H-type hypertension and plaque risk.

Conclusions:

  • H-type hypertension is significantly associated with PCAT inflammatory changes, including attenuation and net enhancement.
  • PCAT net enhancement values derived from CTA are valuable for predicting carotid plaque risk and vulnerability.

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
153
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
475
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
94
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
63
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
85